Diabetes
Feature
Call to Action: Multidisciplinary panel urges coordinated care for ‘NASH epidemic’
From the Journals
Dapagliflozin safe, protective in advanced kidney disease
“This is now the absolute reassurance that we do not have to stop an SGLT2 inhibitor in people with eGFR< 30 mL/min for safety reasons” and...
From the Journals
‘Gold cards’ allow Texas docs to skip prior authorizations
Through this law, doctors in the state will spend less time getting approvals for treatments for their patients.
News
FDA okays extended-release exenatide for children with T2D
It’s the second GLP-1 receptor agonist approved for youth with type 2 diabetes, and the first once-weekly.
From the Journals
‘Wild West’ and weak evidence for weight-loss supplements
News
FDA OKs spinal cord stimulation for diabetic neuropathy pain
From the Journals
Analysis supports CAC for personalizing statin use
A cross-sectional study confirms a coronary artery calcium score of 0 may obviate the need for statins in the context of risk-enhancing factors....
From the Journals
Cycling linked to longer life in people with type 2 diabetes
From the Journals
Statin safety, low muscle pain risk upheld in ‘reassuring’ study
The potential harms are small and the benefit-to-harm balance generally “favorable” for statin use in primary prevention of cardiovascular disease...
Conference Coverage
ADA/EASD draft guidance aims to bring adults with type 1 diabetes out of shadows
The new draft ADA/EASD consensus report offers an algorithm for diagnosing type 1 diabetes, a clear call for state-of-the-art technology, and an...
From the Journals
Metformin use may curb BCC risk
Population-based study shows a potential protective effect of metformin use for basal cell carcinoma, but no effect on risk of squamous cell...